| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |